Management of Bupropion-Induced Anxiety and Insomnia
Immediately discontinue the nighttime 75 mg bupropion dose and consolidate to 150 mg once daily in the morning only, while maintaining fluoxetine 40 mg. 1
Rationale for Immediate Dose Adjustment
Bupropion should be administered in the morning only to minimize insomnia and anxiety; the FDA label explicitly states that extended-release formulations must be given in the morning, and the second dose of immediate-release formulations should not be taken late in the day to reduce insomnia risk. 1
The current regimen of 225 mg total daily (150 mg AM + 75 mg PM) is activating, and evening dosing directly contributes to both anxiety and insomnia through bupropion's dopamine and norepinephrine reuptake inhibition. 2, 3
Trazodone is associated with higher somnolence than bupropion and may be more effective for treating insomnia if sleep disturbance persists after bupropion adjustment. 4
Specific Tapering Protocol
Week 1: Immediate Adjustment
- Stop the 75 mg evening dose immediately (no gradual taper needed for this small dose reduction). 1
- Continue 150 mg bupropion in the morning only. 1
- Maintain fluoxetine 40 mg daily. 2
Weeks 2–4: Monitoring Phase
- Assess anxiety and insomnia severity at 1–2 weeks after eliminating the evening dose; most patients experience rapid improvement in activation-related side effects within this timeframe. 2, 5
- Monitor closely for suicidal ideation, behavioral activation, and worsening depression during the first 1–2 weeks, as required by FDA boxed warnings for all antidepressants. 1
If Anxiety Persists After 2 Weeks
- Consider discontinuing bupropion entirely if anxiety remains problematic despite dose reduction, as bupropion's stimulating properties can provoke anxiety particularly in susceptible patients. 5, 3
- When discontinuing bupropion 150 mg daily, taper to 150 mg every other day for 1 week before stopping to minimize withdrawal symptoms. 1
- Fluoxetine 40 mg alone provides adequate antidepressant coverage and has lower anxiety-provoking potential than bupropion. 4
Managing Persistent Insomnia
Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia disorder and should be offered or arranged regardless of medication adjustments. 6
If insomnia persists after bupropion adjustment, add a sedating agent such as trazodone 25–50 mg at bedtime, which has demonstrated higher somnolence rates than bupropion and is commonly used off-label for insomnia. 4, 3
Avoid benzodiazepines for chronic insomnia due to risks of dependence, cognitive impairment, and potential interactions with other central nervous system depressants. 7, 6
Key Safety Considerations
Bupropion carries seizure risk that increases with higher doses; the maximum recommended dose is 450 mg/day for immediate-release and 400 mg/day for sustained-release formulations, but this patient's 225 mg total is well below threshold. 4, 1
Sexual dysfunction is significantly lower with bupropion (compared to fluoxetine or sertraline), which is a key advantage if the patient experienced sexual side effects on prior SSRIs. 4
Baseline insomnia and anxiety levels do not predict likelihood of antidepressant response to bupropion, but higher baseline insomnia is associated with earlier onset of response (approximately one week sooner). 8
Clinical Pitfalls to Avoid
Do not continue the evening bupropion dose while attempting to manage anxiety and insomnia—the timing of administration is critical to minimizing these side effects. 1
Do not abruptly discontinue bupropion without tapering if total discontinuation becomes necessary; gradual dose reduction prevents withdrawal symptoms. 1
Do not add benzodiazepines to manage anxiety without first eliminating the evening bupropion dose, as this addresses the root cause rather than masking symptoms with additional medications. 7, 6
Do not assume bupropion is contraindicated for all patients with anxiety—clinical trials show comparable efficacy to SSRIs for mild-to-moderate anxiety in depressed patients, but the activating evening dose is the specific problem here. 5, 9, 10